DUAA ALI: Open Payments
NPI 1043941313 · IRVING, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$868 in 28 payments from 8 companies in 2025. Trend: 2023 $261 · 2024 $909 · 2025 $868
Food & beverage: $868
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 9 | $256 |
| Lilly USA, LLC | 5 | $159 |
| AstraZeneca Pharmaceuticals LP | 2 | $148 |
| Novo Nordisk Inc | 4 | $77 |
| Cipher Pharmaceuticals US LLC | 1 | $76 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $67 |
| PFIZER INC. | 3 | $61 |
| Exact Sciences Corporation | 1 | $25 |
Products named: REPATHA, AIRSUPRA, JARDIANCE, MOUNJARO, Ozempic, Natroba, OTEZLA, PAXLOVID.
Industry payments across TX — which companies pay providers there.
